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Bioactive properties and phytochemical
assessment of Bacupari-anão (Garcinia brasiliensis
Mart.) leaves native to Rondônia, Brazil
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Taofiq Oludemi, c Ricardo C. Calhelha, c Tânia C. S. P. Pires, c
Maria José Alves, c Roberto Carlos Campos Martins, b Lillian Barros *c and
Isabel C. F. R. Ferreira *c
Leaf fractions of Garcinia brasiliensis were evaluated concerning their antioxidant, antimicrobial, anti-
inflammatory and cytotoxic properties, and the most active fraction was then fully characterized regarding
its phenolic composition using HPLC-DAD-ESI/MSn. The ethyl acetate fraction from partitioning of the
methanolic leaf extract revealed a strong antioxidant activity that was comparable to Trolox, the positive
control. This fraction was also able to show a significant antimicrobial activity against Gram-positive and
Gram-negative bacteria and the fungus Candida albicans. However, the dichloromethane fraction was
found to present the highest anti-inflammatory (83 ± 9 µg mL−1) and cytotoxic activities, thus presenting
slight toxicity using a non-tumor cell line. Regarding the phenolic profile, the ethyl acetate fraction pre-
sented twelve flavonoids, with morelloflavone-7’’-O-glucoside (52.1 ± 0.4 mg g−1) and gardinia biflavo-
noid 2a glucoside (27.5 ± 0.2 mg g−1) being the major compounds identified. These results indicate that
leaves of G. brasiliensis might be a potential source of natural biomolecules for pharmaceutical and med-
icinal applications.
1. Introduction
Day-to-day oxidative metabolism in the human body generates
free radicals that attack various biomolecules including DNA,
proteins and lipids, leading to some chronic diseases. It is
worth noting that the body is equipped with an intrinsic enzy-
matic antioxidant pool, such as superoxide dismutase (SOD),
catalase and glutathione peroxidase (GP), which neutralizes
some of these free radicals and repairs oxidative damage.1
However, continuous oxidative damage and repair processes
cause dysfunction of the antioxidant system by promoting the
pathogenesis of various diseases, hence the need for exogen-
ous antioxidants.2 The use of natural bioactive compounds
from plants has shown their strong pharmacological pro-
perties, namely anti-inflammatory, antimicrobial, antiparasi-
tic, antimutagenic and anticarcinogenic properties. Thus,
medicinal plants have been recognized as an alternative medi-
cine since ancient times.3
The Amazon rainforest is present in nine countries of
South America (Brazil, Peru, Colombia, Venezuela, Ecuador,
Bolivia, Guyana, Suriname and French Guiana) with 60%
present in the Brazilian territory.4 Ethnopharmacological field-
studies have identified several medicinal species popularly
used for the treatment of a wide range of diseases. Despite the
rich biodiversity of this region, there is still a lack of compre-
hensive studies regarding the uses, bioactivities, chemical
composition and pharmacological properties of many of these
medicinal plants.
The genus Garcinia belongs to the family of Guttiferae
(Clusiaceae) and it is one of the genera found in some parts of
the Amazon forest. This genus includes more than 1000
species whose plant parts (fruits, flowers, leaves, barks and
stems) have attracted a lot of attention because of their second-
ary metabolite composition, being used globally in traditional
medicine to treat disorders such as inflammation, microbial
infections, and cancer.5,6 An increasing number of researchers
are interested in bioactive compounds extracted from Garcinia
species, due to their large use in folk medicine.7,8
Garcinia brasiliensis Mart. is a green plant native to the
Amazon region, cultivated for its edible fruit, popularly†Both authors contributed equally to this work.
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referred to as Bacupari-anão or guapomo, in Brazil and
Ecuador, respectively.9,10 Some of its bioactive properties are
well reported, including antioxidant,9 antidiabetic,10 anti-
inflammatory,11 antispasmodic,7 in vivo photoprotective,12 and
antiprotozoal activities.13 The leaves of G. brasiliensis have also
been used in Brazilian folk medicine for the treatment of
tumors, to suppress the pain associated with arthritis, and for
other inflammatory disorders.14 However, very little work has
been published regarding their phytochemical profiling and
the compounds–bioactivity relationship of extracts from its
vegetative organs.
In view of these pharmaceutical potentials, leaves of
G. brasiliensis were subjected to a cold methanol extraction
and further liquid–liquid partitioning to obtain hexane, di-
chloromethane and ethyl acetate fractions. All fractions were
then tested in search of their antioxidant, anti-inflammatory,
antimicrobial and cytotoxic activities. Furthermore, the pheno-
lic composition of the most bioactive extract was analyzed
using HPLC-DAD-ESI/MSn.
2. Materials and methods
2.1. Collection of plant materials
Leaves of G. brasiliensis were collected at the São Cristóvão
site, located in Lot 11A1, Gleba G, Sector 04, in Presidente
Médici, RO, in September 2017. Identification of the species
was carried out through the evaluation of its botanical charac-
teristics and comparing with those previously reported in
literature by the Botanist Master Joseane Bessa Barbosa.
A voucher specimen was deposited at the Antônio Dalla Martha
Herbarium of the Lutheran University Center of Ji-Paraná
(CEULJI/ULBRA) under number 317. The plant material was
subjected to drying in an oven at 40 °C for seven days and then
crushed in a knife-type mill.
2.2. Preparation of crude alcoholic extract and liquid–liquid
partitioning
Part of the dried and crushed leaves (100 g) of G. brasiliensis
were extracted in cold methanol by exhaustive percolation.
Subsequently, the solvent was evaporated in a rotatory evapor-
ator (Büchi R-210, Flawil, Switzerland) under vacuum and lyo-
philized (FreeZone 4.5, Labconco, Kansas City, MO, USA),
yielding a methanolic extract (11.5 g). This extract was then
subjected to liquid–liquid partitioning, by re-dissolving the
extract in methanol/water (30 : 70) and then extracting it with
hexane, dichloromethane and ethyl acetate, yielding the
hexane (264.6 mg), dichloromethane (916.6 mg) and ethyl
acetate (496.9 mg) fractions.
2.3. Evaluation of bioactive properties
2.3.1. Antioxidant activity. Four different assays were used
to assess the in vitro antioxidant potential of each fraction:
scavenging effects on DPPH (2,2-diphenyl-1-picrylhydrazyl rad-
icals (RSA), reducing power measured by ferricyanide Prussian
blue assay (RP), β-carotene bleaching inhibition (CBI) and
lipid peroxidation inhibition (LPI) by thiobarbituric acid reac-
tive substances (TBARS) assay, following a procedure pre-
viously described by Petropoulos et al.15 All the results
obtained were expressed as EC50 values, corresponding to the
extract concentration that provides 50% of antioxidant activity,
or 0.5 of absorbance in the case of a reducing power assay.
Trolox (6-hydroxy-2,5,7,8-tetramethylchroman 2-carboxylic
acid, Sigma-Aldrich, St Louis, MO, USA) was used as a positive
control.
2.3.2. Anti-inflammatory activity. To assess the anti-inflam-
matory activity, a macrophage-like cell line, RAW 264.7, was
used and cultured following a procedure previously described
by Taofiq et al.16 The nitrite levels produced were determined
by measuring the optical density at 515 nm using a microplate
reader, and the obtained results were compared with the stan-
dard calibration curve. Dexamethasone (50 µM) was used as
the positive control. The results were expressed in EC50 values,
corresponding to the extract concentration that inhibited 50%
of NO production.
2.3.3. Cytotoxic activity. The cytotoxicity was evaluated
using four tumor cell lines, HeLa (cervical carcinoma), HepG2
(hepatocellular carcinoma), MCF-7 (breast adenocarcinoma)
and NCI-H460 (non-small cell lung cancer), using a protocol
previously described by Abreu et al.,17 where the cell growth
inhibition was measured at 540 nm (ELX800 microplate
reader, Bio-Tek Instruments, Inc.; Winooski, VT, USA) using
the sulforhodamine B assay. For non-tumor porcine liver cells
(PLP2) freshly harvested porcine liver was used to obtain the
cell culture, designated as PLP2.
The growth inhibition was evaluated using the sulforhod-
amine B assay and the results were expressed in GI50 values,
corresponding to the extract concentration that inhibited 50%
net cell growth. Ellipticine was used as a positive control.
2.3.4. Antimicrobial activity. The microbial strains were
clinical isolates donated from patients hospitalized in various
departments at the Hospital Center of Trás-os-Montes and Alto
Douro (Vila Real, Portugal). Five Gram-negative bacteria
(Escherichia coli (isolated from urine), Proteus mirabilis (iso-
lated from wound exudate), Klebsiella pneumoniae (isolated
from urine), Pseudomonas aeruginosa (isolated from expectora-
tion) and Morganella morganii (isolated from urine)), and four
Gram-positive bacteria (Enterococcus faecalis (isolated from
urine), Listeria monocytogenes (isolated from cerebrospinal
fluid), methicillin-sensitive Staphylococcus aureus (MSSA) (iso-
lated from wound exudate), and methicillin-resistant
Staphylococcus aureus (MRSA) (isolated from expectoration)),
and a yeast, Candida albicans (isolated from urine), were
tested. All these bacteria were incubated at 37 °C in an appro-
priate fresh medium for 24 h before analysis to maintain the
exponential growth phase, except for Candida albicans, which
was incubated at room temperature for 48 h.
The MIC determination was conducted using a colorimetric
assay according to a procedure previously described by Pires
et al.18 The MIC values were obtained by adding 40 μL of
p-iodonitrotetrazolium chloride (INT, 0.2 mg mL−1) and
further incubation at 37 °C for 30 min.
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MBC were determined by plating on a solid medium 50 μL
of the liquid from each well that showed no changes in colour
and further incubation at 37 °C for 24 h.
Three negative controls were prepared (one with Mueller-
Hinton Broth (MHB), another with the extract, and a third
with medium and antibiotic). One positive control was pre-
pared with MHB and for each inoculum. For the Gram-nega-
tive bacteria, antibiotics, such as ampicillin and imipenem,
were used as positive controls, while ampicillin and vancomy-
cin were used for the Gram-positive bacteria, and fluconazole
was used for the antifungal activity.
2.4. Characterization of phenolic compounds by
LC-DAD-ESI/MSn
The ethyl acetate fraction was dissolved in methanol at a con-
centration of 5 mg mL−1 and filtered through a 0.22 µm dis-
posable LC filter disk. Chromatographic analysis was performed
using a Dionex Ultimate 3000 UPLC (Thermo Scientific, San
Jose, CA, USA) system as previously described by Bessada
et al.19 Double online detection was carried out in a DAD
using 280, 330 and 370 nm as the preferred wavelengths and
in a mass spectrometer (MS) operating in negative mode,
using a Linear Ion Trap LTQ XL mass spectrometer (Thermo
Finnigan, San Jose, CA, USA) equipped with an ESI source.
Data acquisition was carried out with an Xcalibur® data
system (Thermo Finnigan, San Jose, CA, USA). The phenolic
compounds were identified by comparing their retention
times, UV–vis and mass spectra with those obtained from stan-
dard compounds, when available. Otherwise, compounds were
tentatively identified comparing the obtained information
with available data reported in the literature. For a quantitative
analysis, a calibration curve for each available phenolic stan-
dard (catechin, luteolin-6-C-glucoside, apigenin-6-C-glucoside,
quercetin-3-O-glucoside, kampherol-3-O-glucoside, naringen-
ina, and apigenina-7-O-glucoside) was constructed based on
the UV signal. For the identified phenolic compounds for
which a commercial standard was not available, the quantifi-
cation was performed through the calibration curve of the
most similar available standard. The results were expressed as
mg g−1 of the extract.
2.5. Statistical analysis
All assays were carried out in triplicate and the results were
expressed as the mean values and standard deviation (SD).
Analysis was performed through a one-way analysis of variance
(ANOVA) followed by a Tukey’s HSD test with p = 0.05, using
the SPSS v. 23.0 program (IBM Corp., Armonk, New York,
USA).
3. Results and discussion
3.1. Bioactive properties of individual fractions of
G. brasiliensis
The antioxidant activity was assessed using different in vitro
methods with each presenting a different mechanism of
action. Considering that each extract fraction is composed of
different individual compounds, the mechanism by which
they exert an antioxidant effect might also differ. The anti-
oxidant activities of the different fractions of G. brasiliensis are
presented in Table 1. For the DPPH assay, the ethyl acetate
fraction (EC50, 31.2 ± 0.2 μg mL−1) was observed to be the most
significant, indicating a high antioxidant activity comparable
to Trolox. The ferric reducing ability of the samples was
similar to those obtained for the DPPH assay, where the ethyl
acetate fraction presented the most significant antioxidant
capacity (EC50, 68 ± 0.2 μg mL−1), followed by the dichloro-
methane fraction (EC50, 131 ± 0.2 μg mL−1). Similar results
were also obtained in the TBARS and β-carotene bleaching
Table 1 Bioactive properties of G. brasiliensis tested with three different extracts
Ethyl acetate Dichloromethane Hexane Control
Antioxidant activity (EC50 values, µg mL
−1)
DPPH scavenging activity 31.2 ± 0.2c 60 ± 2b 516 ± 13a 41 ± 1
β-Carotene bleaching inhibition 15.9 ± 0.3c 539 ± 9b 600 ± 17a 18 ± 1
Reducing power 68.8 ± 0.2c 131 ± 1b 365 ± 5a 41.7 ± 0.3
TBARS inhibition 4.6 ± 0.2c 23 ± 1b 45.8 ± 0.3a 23 ± 1
Anti-inflammatory activity (EC50 values, µg mL
−1)
Nitric oxide (NO) production 205 ± 9a 83 ± 9c 112 ± 9b 16 ± 1
Cytotoxicity to tumor cell lines (GI50 values, µg mL
−1)
HeLa (cervical carcinoma) 253 ± 1a 41 ± 4c 91 ± 2b 1.91 ± 0.06
HepG2 (hepatocellular carcinoma) 279 ± 7a 57 ± 2c 102 ± 5b 1.1 ± 0.2
MCF-7 (breast carcinoma) 326 ± 20a 60 ± 3c 148 ± 8b 0.91 ± 0.04
NCI-H460 (non-small cell lung cancer) 348 ± 15a 72 ± 4c 117 ± 1b 1.0 ± 0.1
Cytotoxicity to non-tumor cell lines (GI50 values, µg mL
−1)
PLP2 (porcine liver primary culture) >400 303 ± 8 >400 3.2 ± 0.7
Trolox, dexamethasone, and ellipticine were used as positive controls in the antioxidant, anti-inflammatory, and cytotoxic assays, respectively.
The antioxidant activity was expressed as EC50 values, corresponding to the extract concentration corresponding to 50% of antioxidant activity or
0.5 of absorbance in the reducing power assay. Results of the anti-inflammatory activity are expressed in EC50 values: the sample concentration
providing 50% of inhibition of nitric oxide (NO) production. Cytotoxicity results are expressed in GI50 values, corresponding to the sample con-
centration achieving 50% of growth inhibition in human tumor cell lines or in liver primary culture PLP2. In each row, values for each extract fol-
lowed by different Latin letters indicate significant differences among the extracts (p < 0.05).
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assay with the ethyl acetate fraction presenting the highest
antioxidant activity. Significant antioxidant activity of ethanol,
hexane, and ethyl acetate extracts obtained from G. brasiliensis,
prepared by sonication, was reported by Saroni et al.9 The
authors suggest that these results are due to the contribution
of the redox-active bioflavonoid present in the extracts and
several studies have also suggested a strong correlation
between the antioxidant activity of medicinal plants and their
phenolic composition.3,20,21
The in vitro anti-inflammatory potential of each extract frac-
tion was evaluated by measuring NO inhibition. The most
effective fraction was the dichloromethane fraction (EC50, 83 ±
9 μg mL−1), closely followed by the hexane fraction (EC50,
112 ± 9 μg mL−1), and lastly by the ethyl acetate extract (EC50,
205 ± 9 μg mL−1). The ethanolic leaf extract from G. brasiliensis
showed significant anti-inflammatory potential, as reported by
Santa-Cecília et al.14 This activity might also be correlated with
its phenolic content, such as fukugiside, fukugetin A, guttifer-
one A and 7-epiclusianone. A significant contribution of bio-
active flavonoids in G. brasiliensis in the anti-inflammatory
activity was also reported by Castardo et al.11 The authors
induced edema in vivo and exposed paw tissues to hydroalco-
holic extracts of G. brasiliensis. Results showed a significant
increase in paw edema with the reduction in inflammatory
mediator release. Considering that inflammation is a central
feature of many pathophysiological conditions, fractions from
the crude extract have been able to inhibit the production of
the inflammatory mediator (NO) and can be a potential source
of biomolecules used to suppress the severity of inflammatory
disease.
The cytotoxic activity of each fraction was evaluated in non-
tumor porcine liver cells (PLP2) and in tumor cell lines (breast
carcinoma – MCF-7, non-small cell lung carcinoma –
NCI-H460, cervical carcinoma – HeLa and hepatocellular carci-
noma – HepG2), and the results are presented in Table 1. The
ethyl acetate and hexane fraction did not show hepatotoxicity
against PLP2 cells up to the maximal tested concentration
(GI50 > 400 μg mL−1). However, the dichloromethane fraction
showed hepatotoxicity against this cell line (GI50, 303 ± 8
μg mL−1), and this might be due to the antagonistic contri-
bution of some compounds present in the extracts. Regarding
the cytotoxic effects in tumor cell lines, the three fractions
showed an inhibitory capacity and the dichloromethane frac-
tion was the most effective against all the cell lines evaluated.
However, the cytotoxic effect of both ethyl acetate and di-
chloromethane fractions showed a similar order of effective-
ness against the tested cell lines HeLa > HepG2 > MCF-7 >
NCI-H460. Regarding the dichloromethane fraction, the
results obtained in Table 1 show that the concentration
required to achieve 50% of growth inhibition of PLP2 is about
4 times higher than the concentration required to achieve 50%
of growth inhibition of all the human tumor cell lines tested.
Therefore, a dosage of 72 µg mL−1, which was the highest GI50
value obtained (NCI-H460), could be recommended for further
studies, in order to guarantee 50% of growth inhibition of the
above tested human tumor cell lines, without presenting tox-
icity effects on non-tumor cells. Benzophenone 7-epiclusia-
none was isolated from the epicarp of G. brasiliensis and tested
against glial tumor cell lines (U138MG).22 This compound was
able to inhibit cell viability and showed 50% of growth inhi-
bition (18.52 ± 0.50 μM). A cytotoxic advancement was reported
by Ionta et al.23 for 7-epiclusianone, showing inhibition of
human lung adenocarcinoma cell lines (A549) at 16.13 ±
1.12 μM and the authors reported cell arrest in G1/S transition
phase and induction of the apoptosis process. However, most
of these reports available in the literature were carried out on
the fruit of G. brasiliensis and to the best of our knowledge,
this is the first report showing a promising prospect for cyto-
toxic compounds present in leaves of this species.
The results on the antimicrobial activity of each extract frac-
tion are presented in Table 2, expressed as MICs (Minimum
Inhibitory Concentration, mg mL−1) and MBC (Minimum
Bactericidal Concentration, mg mL−1). Hexane and dichloro-
methane fractions were not able to demonstrate bactericidal
activity up to 20 mg mL−1 against all the microorganisms
tested, with the exception of the hexane fraction which was
able to inhibit MRSA and MSSA. However, the ethyl acetate
fraction was able to display a broader spectrum antimicrobial
activity against all the tested microorganisms with MIC values
between 10 and 20 mg mL−1. A previous research study con-
ducted by Naldoni et al.24 reported antimicrobial activity for
7-epiclusianone (1.2 µg mL−1) and guttiferone-A (2.4 µg mL−1),
isolated from the pericarp and seeds of G. brasiliensis, against
Candida albicans, Staphylococcus aureus, Escherichia coli, and
Bacillus cereus. So far, this is the only report on the anti-
microbial activity of extracts and/or isolated compounds from
the leaves of G. brasiliensis. In general, these extracts show
high antimicrobial potential against Gram-positive bacteria
and might be able to accumulate novel compounds that can be
used to control diseases associated with Gram-positive
bacteria.
3.2. Identification of phenolic compounds in the ethyl
acetate fraction of G. brasiliensis
The results regarding the phenolic profile obtained by
HPLC-DAD-ESI/MSn analysis of the ethyl acetate fraction of
G. brasiliensis are shown in Table 3. This phenolic profile
(Fig. 1) revealed the presence of twelve phenolic compounds,
comprising five bioflavonoids, four flavones, two flavonols and
one flavan-3-ol. The identification of the phenolic compounds
was performed taking into account previous reports of chemi-
cal studies in Garcinia6,25,26 and other plant species.27
Bioflavonoids were the most abundant compounds present
in G. brasiliensis. These compounds are described to be very
characteristic of Garcinia species. Compound 9 ([M − H]− at
m/z 717) was tentatively identified as morelloflavone-7″-O-glu-
coside by examining its UV spectrum and mass fragmentation,
and it was previously described in the ethyl acetate epicarp
extract of G. brasiliensis.6 Compound 8 ([M − H]− at m/z 719)
was identified as biflavonoid 2a glucoside (GB-2ª-glucoside)
and it was previously reported to be isolated from the
branches, leaves and fruit of Garcinia oblongifolia Champ. ex
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Benth.,28 ethanol/water seed extract of Garcinia madruno
(Kunth) Hammel,29 and leaves of Garcinia multiflora Champ.
ex Benth.30 Both compounds 8 and 9 have been previously
reported in different Garcinia species, namely Garcinia kola
Heckel seed extract,31 Garcinia gardneriana (Planch. & Triana)
Zappi leaf extract11 and Garcinia griffithii T. Anders. leaf
extract.26 Due to the consistent presence of these compounds
in these species, they are considered to be chemotaxonomic
markers for the genus Garcinia. Compound 10 ([M − H]− at
m/z 703) was identified as binaringenin-7″-O-glucoside, taking
into account the findings presented by Salleh et al.,26 who
studied the leaves and stem bark extracts from G. griffithii.
Compound 11 ([M − H]− at m/z 701) was tentatively identified
as volkensiflavone-7″-O-glucoside by examining its UV–VIS
spectrum and mass fragmentation and it was previously
described in the ethanol/water seed extract of G. madruno.29
Compound 12 ([M − H]− at m/z 555) was identified as morello-
flavone according to its mass and UV–VIS characteristics as
previously reported.6
Other compounds were identified as 1 (catechin), 2 (luteo-
lin-6-C-glucoside), 4 (apigenin-8-C-glucoside), 5 (apigenin-6-C-
glucoside), 6 (quercetin-3-O-glucoside), and 7 (kaempferol-3-O-
glucoside). They were unequivocally identified according to
their retention time, mass and UV characteristics by compari-
son with commercial standards. Compound 3 ([M − H]− at m/z
577) was identified as apigenin 2″-O-deoxyhexoside-C-hexo-
side, taking into account the findings described by Ferreres
et al.32 So far, this is the first report on the presence of these
compounds in G. brasilienses and both peaks 4 (21.2 ± 0.2
mg g−1) and 3 (19.0 ± 0.3 mg g−1) were present in high
concentrations.
Two bioflavonoids, namely morelloflavone-7″-O-glucoside
(52.1 ± 0.4 mg g−1) and gardinia biflavonoid 2a glucoside (27.5 ±
0.2 mg g−1), were the major compounds among the phenolics,
representing 34% and 18%, respectively, of the phenolic
composition.
Some bioflavonoids have been reported in the literature
to be bioactives. Castardo et al.11 reported the anti-inflam-
matory effect of hydroalcoholic leaf extracts from
G. gardneriana and suggested that it might be attributed to
the presence of gardinia biflavonoid 2a glucoside. The
authors also tested the anti-inflammatory activity of the iso-
lated compound and compared it to the one of the extract.
Morelloflavone-7″-O-glucoside was isolated from the
epicarp of G. brasiliensis and showed a high antioxidant
activity using DPPH radical scavenging and reducing power
assays (IC50, 52.4 ± 7.60 and 0.250 ± 0.043 µg mL
−1, respect-
ively).6 DPPH scavenging activity (108.1 ± 0.9 µg mL−1) was
also reported for morelloflavone-7″-O-glucoside isolated
from the leaves and stem bark of G. griffithii.26
Morelloflavone-7″-O-glucoside and morelloflavone were iso-
lated from the root bark of Allanblackia floribunda Oliv. and
both the compounds were found to present broad spectrum
antimicrobial activity against Gram-positive and Gram-
negative bacteria and fungi with MICs values between 19.53
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Therefore, the interesting bioactive properties presented in
the present work may be due to the contribution of these com-
pounds, hence there is a need to conduct more comprehensive
studies related to these individual compounds in order to
enhance their exploration in pharmaceutical and medicinal
chemistry.
4. Conclusion
Garcinia brasiliensis is an interesting medicinal plant native to
the Amazon region which is primarily cultivated for its fruits.
However, several medicinal effects have been attributed to its
various plant parts because of the significant amount of bio-
Table 3 Retention time (Rt) wavelengths of maximum absorption in the visible region (λmax), mass spectral data, tentative identification and quantifi-







ion [M − H]− (m/z) MS2 (m/z) Tentative identification
Quantification
(mg g−1) Identification type
1 9.5 280 289 245(100), 205(20),
161(5), 137(5)
(+)-Catechin1 7.5 ± 0.1 DAD. MS. commercial
standard
2 14.4 345 447 429(6), 357(50),
327(100)
Luteolin-6-C-glucoside2 7.5 ± 0.2 DAD. MS. commercial
standard




19.0 ± 0.3 32
4 16.2 337 431 413(5), 341(12),
311(100)
Apigenin-8-C-glucoside3 21.2 ± 0.2 DAD. MS. commercial
standard
5 18.1 336 431 413(5), 341(12),
311(100)
Apigenin-6-C-glucoside3 5.1 ± 0.1 DAD. MS. commercial
standard
6 18.8 346 463 301(100) Quercetin-3-O-glucoside4 1.50 ± 0.03 DAD. MS. commercial
standard
7 22.2 330 447 285(100) Kaempferol-3-O-glucoside5 0.86 ± 0.02 DAD. MS. commercial
standard
8 26.0 288. sh340 719 557(100) Gardinia biflavonoid 2a
glucoside (GB-2ª-glucoside)6
27.5 ± 0.2 27,28
9 27.3 346 717 555(100) Morelloflavone-7″-O-
glucoside7
52.1 ± 0.4 6,27
10 31.0 288. sh340 703 541(100) Binaringenin-7″-O-glucoside6 3.57 ± 0.04 26
11 32.2 330 701 539(100) Volkensiflavone-7″-O-
glucoside7
6.23 ± 0.06 27,29
12 36.5 340 555 429(100), 401(5),
385(3), 357(3),
341(5), 295(3)
Morelloflavone7 1.93 ± 0.03 6,25,27
Total phenolic compounds 154 ± 2 —
Calibration curves used – 1: catechin (y = 84950x − 23 200; R2 = 0.999); 2: luteolin-6-C-glucoside (y = 4087.1x + 72 589; R2 = 0.999); 3: apigenin-6-
C-glucoside (y = 4087.1x + 72 589; R2 = 0.999); 4: quercetin-3-O-glucoside (y = 34843x − 160 173; R2 = 0.999); 5: kampherol-3-O-glucoside (y =
11117x + 30 861; R2 = 0.999); 6: naringenina (y = 18433x + 78 903; R2 = 0.999); 7: apigenina-7-O-glucoside (y = 10683x − 45 794; R2 = 0.996).
Fig. 1 Phenolic profile of a G. brasiliensis ethyl acetate extract recorded at 280 nm.
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active molecules. The results of the present work reveal that
the different fractions obtained from the crude methanolic
extract possess antioxidant capacity, being more pronounced
in the ethyl acetate fraction. The dichloromethane fraction was
more efficient in the anti-inflammatory and cytotoxic activities.
For the antimicrobial assay, the ethyl acetate fraction revealed
broad spectrum microbial inhibition against Gram-negative
and Gram-positive bacteria and the fungus Candida albicans.
The phenolic profile of the ethyl acetate fraction was achieved
by HPLC-DAD-ESI/MSn analysis and this fraction revealed
itself as the most promising among others for all the activities
tested. In this fraction, 12 flavonoid compounds were identi-
fied and morelloflavone-7″-O-glucoside and gardinia biflavo-
noid 2a glucoside were the most abundant. This work shows
that the leaves of G. brasiliensis are an attractive source of bio-
active molecules with interesting health-promoting benefits,
suitable to be explored for pharmaceutical, food and even cos-
meceutical applications.
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